India's Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19
![](https://img.etimg.com/thumb/msid-82514882,width-1070,height-580,imgsize-254885,overlay-economictimes/photo.jpg)
Baricitinib has been given restricted emergency use approval by India's drug regulator for use in combination with remdesivir for the treatment of hospitalised COVID-19 adult patients requiring supplemental oxygen, Cipla said in a filing to stock exchanges.
via Economictimes
Post a Comment